Xenon Pharmaceuticals

XENE • NASDAQ • Stock Fundamentals

Xenon Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrea DiFabio, with a market cap of $5.3B.

Market Cap$5.3B

Employees259.0

CEOAndrea DiFabio

CountryCanada

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 5 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Xenon Pharmaceuticals

Xenon Pharmaceuticals (XENE) has a market capitalization of $5.3B and trades on NASDAQ.

Xenon Pharmaceuticals has approximately 259 employees.